GeoVax Labs Return on Equity (ROE) Growth & History (GOVX)

GeoVax Labs's return on equity was −483.79% for fiscal 2025.

View full GeoVax Labs company overview

GeoVax Labs annual return on equity history

GeoVax Labs annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20252025-12-31−483.79%−21.47 pp
20242024-12-31−462.31%−301.84 pp
20232023-12-31−160.47%−69.90 pp
20222022-12-31−90.57%+176.04 pp
20212021-12-31−266.61%−192.61 pp
20202020-12-31−74.00%
20162016-12-31−452.84%−224.04 pp
20152015-12-31−228.80%−79.97 pp
20142014-12-31−148.83%−24.59 pp
20132013-12-31−124.24%+106.02 pp
20122012-12-31−230.26%−45.46 pp
20112011-12-31−184.80%−86.34 pp
20102010-12-31−98.46%+3.31 pp
20092009-12-31−101.77%+37.40 pp
20082008-12-31−139.17%+35.71 pp
20072007-12-31−174.88%−106.26 pp
20062006-12-31−68.62%
20042004-12-31−974.01%−160.51 pp
20032003-12-31−813.50%

GeoVax Labs return on equity trends

Over the last five fiscal years, GeoVax Labs's return on equity decreased from −74.00% to −483.79%, a change of −409.78 percentage points. The latest reported quarter, Q2 2026, shows −392.69%.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review GeoVax Labs source filings ↗

Community posts

It’s quiet here.

No posts about GOVX yet. Start the conversation.

Write the first post